期刊
WORLD JOURNAL OF GASTROENTEROLOGY
卷 27, 期 25, 页码 3780-3789出版社
BAISHIDENG PUBLISHING GROUP INC
DOI: 10.3748/wjg.v27.i25.3780
关键词
Hepatocellular carcinoma; Interventional radiology; Oncology; Liver; Management; COVID-19
The COVID-19 pandemic has impacted hospital organization, leading to modifications in the management of oncological patients, including different allocation of nurses and doctors, and requiring new strategies to ensure correct assistance for patients. Additionally, hepatocellular carcinoma, considered one of the most aggressive types of liver cancer, has also required different management during this period in order to optimize care for patients at risk.
The coronavirus disease 2019 (COVID-19) pandemic has impacted hospital organization, with the necessity to quickly react to face the pandemic. The management of the oncological patient has been modified by necessity due to different allocation of nurses and doctors, requiring new strategies to guarantee the correct assistance to the patients. Hepatocellular carcinoma, considered as one of the most aggressive types of liver cancer, has also required a different management during this period in order to optimize the management of patients at risk for and with this cancer. The aim of this document is to review recommendations on hepatocellular carcinoma surveillance and management, including surgery, liver transplantation, interventional radiology, oncology, and radiotherapy. Publications and guidelines from the main scientific societies worldwide regarding the management of hepatocellular carcinoma during the COVID-19 pandemic were reviewed.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据